...an uninformed decision based on commercial requirements alone may, ultimately, have disastrous consequences on the efficacy of the target recombinants.
Jennifer L. Halsall
Advertisement
Articles by Jennifer L. Halsall
Advertisement
Latest Updated Articles
Successful strategies for product optimizationPublished: October 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
